Hair Loss Firm Veradermics Jumps 124% After $256 Million IPO
Shares of hair-restoration drug developer Veradermics Inc. more than doubled in the company’s trading debut after it raised $256.3 million in an initial public offering.
By Avalon Pernell · Bloomberg Markets
Shares of hair-restoration drug developer Veradermics Inc. more than doubled in the company’s trading debut after it raised $256.3 million in an initial public offering.